BioSystem Development secures angel funding

BioSystem Development secures angel funding

Madison, Wis. – A Middleton developer of pharmaceutical research tools will receive at least $715,000 in angel funding from two Wisconsin sources, Silicon Pastures and Marshfield Investment Partners.
BioSystem Development, LLC, which was founded in 2002, will receive $465,000 from Silicon Pastures, a Milwaukee-based network of angel investors, and a minimum of $250,000 from Marshfield Investment Partners, a group of angel investors established to support early-stage companies in the Marshfield region and statewide.
BioSystem has developed a protein analysis device to help pharmaceutical and life-science researchers conduct immune system tests faster, and it is close to commercializing its product. Teresa Esser, managing director of Silicon Pastures, said a lack of monetary capital was preventing BioSystem from building and delivering the biomedical device to customers.
The company, a co-winner of the 2004 Governor’s Business Plan Contest, has been designated as a qualified business venture under Wisconsin Act 255, which provides state tax credits to angel and venture investment funds that invest in designated companies.
Related stories
Business plan finalists offer peek into entrepreneurial future
Winners of past business plan contests secure funding, credibility
Madison biotechs get Commerce grants
Five more companies eligible for angel tax credits
Governor’s business-plan contest has a surprise ending